Parliamentary Search

Written question asked by Lord Boateng (Labour) on Friday, 3 December 2021, in the House of Lords. It was due for an answer on Friday, 17 December 2021. It was answered by Lord Callanan (Conservative) on Friday, 17 December 2021 on behalf of the Department for Business, Energy and Industrial Strategy.

Coronavirus: Vaccination

Question

To ask Her Majesty's Government what assessment they have of the decision by the government of Switzerland to pass their contracted doses of the Moderna vaccine to the COVAX scheme; and what plans they have, if any, to do the same.

Answer

Continued collective global efforts will be crucial to address vaccine inequities. The UK has worked from the start of the pandemic to support equitable access, helping to establish a COVAX to support both higher- and lower-income countries secure the vaccines they need. We invested approximately £71 million to help COVAX secure early supply deals with manufacturers and donated £548 million to the COVAX Advanced Market Commitment to support the procurement of vaccines for lower and middle-income economies, making the UK one of the earliest and largest COVAX donors.

The UK Government through Vaccines Taskforce proactively manages its vaccine supply so that all procured doses are either used rapidly by our domestic programme or shared internationally. This is as per our commitment at the G7 to donate 100 million doses by the end of June 2022, with 30m by the end of 2021.

Secondary information

Type
Written question
Reference
HL4673
Session
2021-22
Subjects
Developing countries International assistance Vaccination Coronavirus Moderna
Link
View this Written question on www.parliament.uk